Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1842 1
1930 1
1931 1
1932 1
1933 2
1934 1
1938 1
1945 1
1946 5
1947 7
1948 5
1949 5
1950 6
1951 3
1952 3
1953 3
1954 3
1955 6
1956 6
1957 8
1958 8
1959 6
1960 5
1961 5
1962 6
1963 7
1964 7
1965 10
1966 3
1967 7
1968 2
1969 4
1970 6
1971 8
1972 5
1973 7
1974 4
1975 6
1976 7
1977 7
1978 13
1979 9
1980 10
1981 11
1982 13
1983 15
1984 14
1985 17
1986 11
1987 17
1988 14
1989 26
1990 25
1991 20
1992 12
1993 24
1994 27
1995 23
1996 18
1997 23
1998 29
1999 27
2000 21
2001 31
2002 31
2003 47
2004 58
2005 58
2006 62
2007 78
2008 59
2009 53
2010 55
2011 63
2012 64
2013 58
2014 45
2015 51
2016 61
2017 61
2018 46
2019 64
2020 57
2021 60
2022 46
2023 37
2024 45
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,798 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint therapy-current perspectives and future directions.
Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, Liu J, Subudhi SK, Poon C, Gant KL, Herbrich SM, Anandhan S, Islam S, Amit M, Anandappa G, Allison JP. Sharma P, et al. Among authors: allison jp. Cell. 2023 Apr 13;186(8):1652-1669. doi: 10.1016/j.cell.2023.03.006. Cell. 2023. PMID: 37059068 Free article. Review.
The future of immune checkpoint therapy.
Sharma P, Allison JP. Sharma P, et al. Among authors: allison jp. Science. 2015 Apr 3;348(6230):56-61. doi: 10.1126/science.aaa8172. Science. 2015. PMID: 25838373 Review.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Cascone T, William WN Jr, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G Jr, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Cascone T, et al. Among authors: allison jp. Nat Med. 2021 Mar;27(3):504-514. doi: 10.1038/s41591-020-01224-2. Epub 2021 Feb 18. Nat Med. 2021. PMID: 33603241 Free PMC article. Clinical Trial.
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, Mulder GE, Toebes M, Vesely MD, Lam SS, Korman AJ, Allison JP, Freeman GJ, Sharpe AH, Pearce EL, Schumacher TN, Aebersold R, Rammensee HG, Melief CJ, Mardis ER, Gillanders WE, Artyomov MN, Schreiber RD. Gubin MM, et al. Among authors: allison jp. Nature. 2014 Nov 27;515(7528):577-81. doi: 10.1038/nature13988. Nature. 2014. PMID: 25428507 Free PMC article.
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.
Zhou Y, Medik YB, Patel B, Zamler DB, Chen S, Chapman T, Schneider S, Park EM, Babcock RL, Chrisikos TT, Kahn LM, Dyevoich AM, Pineda JE, Wong MC, Mishra AK, Cass SH, Cogdill AP, Johnson DH, Johnson SB, Wani K, Ledesma DA, Hudgens CW, Wang J, Wadud Khan MA, Peterson CB, Joon AY, Peng W, Li HS, Arora R, Tang X, Raso MG, Zhang X, Foo WC, Tetzlaff MT, Diehl GE, Clise-Dwyer K, Whitley EM, Gubin MM, Allison JP, Hwu P, Ajami NJ, Diab A, Wargo JA, Watowich SS. Zhou Y, et al. Among authors: allison jp. J Exp Med. 2023 Feb 6;220(2):e20221333. doi: 10.1084/jem.20221333. Epub 2022 Nov 11. J Exp Med. 2023. PMID: 36367776 Free PMC article.
Axial muscle weakness.
Waheed W, Allison JB, Dewitt J, Hallman S, Tandan R. Waheed W, et al. Among authors: allison jb. Pract Neurol. 2020 Dec 1:practneurol-2020-002736. doi: 10.1136/practneurol-2020-002736. Online ahead of print. Pract Neurol. 2020. PMID: 33262222 Review.
Checkpoints.
Allison JP. Allison JP. Cell. 2015 Sep 10;162(6):1202-5. doi: 10.1016/j.cell.2015.08.047. Cell. 2015. PMID: 26359978 Free article. No abstract available.
1,798 results